MET and non-small cell lung carcinoma: Although MET exon 14 alterations were originally identified in small cell lung cancers (SCLCs),76 subsequent studies have found that these genetic variants are more common in NSCLC, accounting for approximately 3−4% of cases.72, 73, 77, 78